4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001209191-22-034387
Options or other derivatives
- Director acquired 8,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Conner Edward R. · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-06-02 | Grant or award : show line 1 in the form Stock Options (Right to Buy) | +8,500 | 8,500 | D |
Loading xslF345X03/doc4.xml…